2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 28852212 | Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen. | 2017 Aug 29 | 2 |
2 | 24663045 | Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer. | 2014 Apr 20 | 4 |